Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Multiple Sclerosis

Scots mum's memory loss and confusion after holiday turned out to be chronic illness triggered by heat

Weeks after returning to Scotland from Morocco, Linda Hoskins was diagnosed with Multiple Sclerosis (MS).

Daily Record

Almost 600 patients diagnosed with multiple sclerosis in 2021

ALMOST 600 patients were diagnosed with multiple sclerosis (MS) in Scotland in 2021.

The National (Scotland)

Briton finishes epic US cycle ride for multiple sclerosis fundraising

Antony Butcher reaches San Francisco after pedalling 4,000 miles from New York and raising £25,000

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Sanofi Shares Are Falling Today

The FDA has placed Sanofi SA's (NASDAQ:SNY) Phase 3 studies of tolebrutinib in multiple sclerosis and myasthenia gravis on partial clinical hold. New enrollment in the U.S. is paused, and participants in the U.S. who have been in the trial for fewer than 60 days shall suspend the study drug. The participants who…

Benzinga

Jazz Pharmaceuticals' Late-Stage Multiple Sclerosis Study Misses Primary Endpoint

Jazz Pharmaceuticals (NASDAQ: JAZZ) announced top-line results from the Phase 3 clinical trial investigating nabiximols oromucosal spray (JZP378) on clinical measures of spasticity in individuals with multiple sclerosis (MS).

Benzinga

Jazz Pharma's Cannabidiol Mixture Spray Misses Primary Goal In Multiple Sclerosis Spasticity

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced topline results from the Phase 3 RELEASE MSS1 trial of nabiximols oromucosal spray on clinical measures of spasticity in multiple sclerosis. The trial did not meet the primary endpoint of change in Lower Limb Muscle Tone-6 (LLMT-6) between baseline and Day 21. Nabiximols oromucosal spray is a complex…

Benzinga

Ray Of Hope: Protein Study Could Pave Way For New Multiple Sclerosis Therapy

"Our results are a window of opportunity for new research strategies of demyelinating diseases such as MS."

Zenger

Read news from The Economist, FT, and more,
with one subscription

DEA Stonewalling MMJ's MS & Huntington's Disease Clinical Trials For 3 Years

MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much coveted orphan drug designation from the FDA for its planned Huntington's disease trials, and has also received a D

Benzinga

Meet the champion snowboarder who has no feeling below her knees

Nina Sparks, 31, refused to let her love affair with mountain sports end after she was diagnosed with multiple sclerosis in March 2021

The Independent UK

TLSA: Clinical Improvements for 2nd SPMS Patient

By John Vandermosten, CFA NASDAQ:TLSA Clinical Results for Second SPMS Patient

Benzinga

'I was diagnosed with MS at the age of 27 after struggling to walk or see properly'

Laura Marsden hadn’t heard of multiple sclerosis so the process of diagnosis was a total shock

Wales Online

Tiziana Life Sciences Shares Jump After Multiple Sclerosis Data From Second Patient

Tiziana Life Sciences (NASDAQ: TLSA) reported clinical results from the second patient with Secondary Progressive Multiple Sclerosis (SPMS) in the ongoing study as part of an expanded access program.

Benzinga

Scots man tells how hot flush turned out to be early symptom of multiple sclerosis

Leuchie House ambassador Alan Kyle tells of his shock at being diagnosed with Multiple Sclerosis and how his 76-year-old mum is his lifeline

Daily Record

Multiple sclerosis researcher swaps lab for great outdoors to complete huge charity challenge in Highland Perthshire

Dr Irene Molina-González (34) will take on the Full Tilt Ultra during the Blair Castle Trail Weekender, near Pitlochry

Daily Record

Get all your
news in one place.

100’s of premium titles.
One news app.

The Times of India

Activists condemn exclusion of 16 disabilities by Tamil Nadu welfare board

CHENNAI: On World Multiple Sclerosis (MS) Day, disability rights activists highlighted the exclusion of people with the condition and other disabilities from government welfare schemes.

The Times of India

World Multiple Sclerosis Day: Women are thrice as likely to develop Multiple Sclerosis than men

Majorly causing complications with vision, balance, muscle control and other bodily functions, Multiple Sclerosis (MS) is a chronic disease that affects the brain spinal cord and the optic nerves. While the condition affects everyone (suffering from the condition) differently, some may have mild symptoms and may not require any treatment…

Daily Mirror

Woman only eats crisp sandwiches for every lunch and dinner for 23 years

Zoe Sadler only ate cheese and onion crisp sandwiches for 23 years and turned to a hypnotist after being diagnosed with multiple sclerosis. She was cured after two two-hour hypnotherapy sessions

Benzinga

Read Why Did HC Wainwright Cut Price Target On Atara Biotherapeutics

Late last week, Atara Biotherapeutics Inc (NASDAQ:ATRA) announced that Bayer AG (OTC:BAYRY) intends to terminate the exclusive worldwide licensing agreement for Atara's mesothelin-targeted allogeneic and autologous CAR-T assets, ATA3271 and ATA2271. The enrollment was paused in the Phase 1 trial of ATA2271 for mesothelioma after a patient death. The move followed a strategic review and asset-level prioritization.…

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Former West Coast Eagles player and AFL mark of the year winner Ashley Sampi reveals he has multiple sclerosis

Former high-flying West Coast Eagles player Ashley Sampi posts on social media announcing his multiple sclerosis diagnosis and committing to raise funds to fight the disease.

Benzinga

Read Why Biogen Shares Are Trading Higher After Q1 Earnings

Biogen Inc (NASDAQ:BIIB) posted Q1 sales of 2.53 billion, beating the consensus of $2.49 billion, down 6% Y/Y. Multiple sclerosis (MS) revenue, including royalties on sales of Ocrevus, of $1.79 billion decreased by 3%. Spinraza's revenue of $441 million decreased 9% at actual currency and 6% at constant currency. Aduhelm's revenue was…

Daily Record

Brave Ayr woman's vow to live life to the full as she battles relapsing multiple sclerosis

Laura Ingram admits she cannot afford to have a lazy day – in case her condition worsens.

Leeds Live

Leeds woman worried about her future as she struggles with multiple sclerosis

Sarah Scarce 29, often worries she could struggle to pay the bills due to her unpredictable symptoms

The National (Scotland)

Defying the odds: Mum runs for city council after MS diagnosis last year

A YES-supporting mum with multiple sclerosis (MS) has shared how her diagnosis finally gave her the confidence to run for election for the SNP.

Edinburgh Live

Young Edinburgh mum diagnosed with MS left 'on edge' over family's uncertain future

Shannon Turnbull, from Edinburgh, was suddenly left unable to walk after suffering a multiple sclerosis relapse in January - despite not knowing she had the condition.

Daily Record

Young Scots mum diagnosed with MS left 'on edge' over family's uncertain future

Shannon Turnbull, from Edinburgh, was suddenly left unable to walk after suffering a multiple sclerosis relapse in January - despite not knowing she had the condition.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Jazz Pharmaceuticals plc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.